Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Current status of hematopoietic stem cell transplantation in Taiwan

Abstract

In Taiwan, hematopoietic SCT (HSCT) has been used to treat patients with hematological diseases since 1983. Since then, more than 2200 patients have undergone HSCT in 15 large hospitals. The disease entities included acute leukemia in 37% of cases, non-Hodgkin's lymphoma in 26%, CML in 10%, multiple myeloma in 7% and severe aplastic anemia in 6%. The conditioning regimens used were mainly myeloablative (84% of cases). Non-myeloablative regimens were fludarabine-based. The average age of allogeneic recipients was at least 10 years older than those in the era before their application. The grafts of all patients were derived from peripheral blood in 85% of cases, BM in 13% and cord blood (CB) in 2%. Forty percent of HSCT patients received autologous grafts, whereas more than 25% of allogeneic HSCT patients received grafts from unrelated donors, and overall, there were more than 200 Taiwan HSCT recipients. Currently, CB has been used successfully in pediatric patients with thalassemia major and also in adult patients with hematological malignancy. After transplantation, there was a relatively lower prevalence of acute GVHD. However, a relatively higher proportion of hepatitis B carriers in the recipients had led to a higher incidence of viral reactivation and clinical hepatitis, which was dramatically decreased following lamivudine prophylaxis. In conclusion, HSCT has been successfully adapted to routine clinical care in Taiwan. Several important findings contributing to the progress of HSCT in the past two decades have also been noticed on this island.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Data from Government Information Service, Republic of China (Taiwan) at http://www.gio.gov.tw/.

  2. Chen PM, Tzeng CH, Chuang MW, Liu JH, Hsieh RK, Liu CJ et al. Twenty patients with hematologic malignancies treated by allogeneic bone marrow transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 1987; 40: 425–430.

    CAS  Google Scholar 

  3. Chen PM, Tzeng CH, Fan FS, Hsieh RK, Wei CH . Bone marrow transplantation in Taiwan: low incidence of acute GVHD in patients with hematologic malignancies and severe aplastic anemia. Bone Marrow Transplant 1994; 13: 709–711.

    CAS  PubMed  Google Scholar 

  4. Chen YC, Lin KH, Huang WS, Tang JL . Bone marrow transplantation in Taiwan: an overview. Bone Marrow Transplant 1994; 13: 705–708.

    CAS  PubMed  Google Scholar 

  5. Hung GY, Chiou TJ, Hsieh YL, Chen PM, Hwang B . Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia. Bone Marrow Transplant 2002; 29: 67–70.

    Article  Google Scholar 

  6. Lee MY, Chiou TJ, Bai LY, Hsiao LT, Hung GY, Chang CY et al. Intravenous busulfan as preparative regimen in pediatric patients receiving hematopoietic stem cell transplantation: the preliminary experience in Taiwan. J Chin Med Assoc 2004; 67: 117–122.

    PubMed  Google Scholar 

  7. Tzeng CH, Lin JS, Chen PM, Hu HY, Lyou JY, Chen YR . Allogeneic peripheral blood progenitor cell transplantation: the Taiwan experience. Transfusion 1997; 37: 244–246.

    Article  CAS  Google Scholar 

  8. Shaw CK, Lin CL, Li CC, Lee TD, Tseng WP . Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR). Bone Marrow Transplant 1999; 23: 727–730.

    Article  CAS  Google Scholar 

  9. Lee TD . Marrow donor registry and cord blood bank in Taiwan. Int J Hematol 2002; 76 (Suppl 1): 312–314.

    Article  Google Scholar 

  10. Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R . Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant 2005; 11: 349–353.

    Article  Google Scholar 

  11. Poh SB, Hsiao LT, Yang CF, Chiou TJ, Chen PM . Fatal early-onset epstein-barr virus-associated post transplantation lymphoproliferative disease after successful adult dual-unit umbilical cord blood transplantation. Biol Blood Marrow Transplant 2005; 11: 732–733.

    Article  Google Scholar 

  12. Hung GY, Chiou TJ, Chang CY, Teng HW, Chen PM, Hwanga B . Double-unit unrelated cord blood transplantation for chronic myelogenous leukemia. Int J Hematol 2005; 82: 159–161.

    Article  Google Scholar 

  13. Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R . Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 2007; 40: 307–311.

    Article  Google Scholar 

  14. Bai LY, Chiou TJ, Liu JH, Yen CC, Wang WS, Yan MH et al. Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan. Ann Hematol 2004; 83: 38–43.

    Article  CAS  Google Scholar 

  15. Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW et al. Complications of bone marrow transplantation in Chinese. Haematol Blood Transfus 1990; 33: 712–714.

    CAS  PubMed  Google Scholar 

  16. Chen PM, Fan S, Hsieh RK, Liu RS, Tzeng CH, Chiou TJ et al. Liver disease in patients with liver dysfunction prior to bone marrow transplantation. Bone Marrow Transplant 1992; 9: 415–419.

    CAS  PubMed  Google Scholar 

  17. Chen PM, Liu JH, Fan FS, Hsieh RK, Wei CH, Liu RS et al. Liver disease after bone marrow transplantation—the Taiwan experience. Transplantation 1995; 59: 1139–1143.

    Article  CAS  Google Scholar 

  18. Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990; 49: 708–713.

    Article  CAS  Google Scholar 

  19. Chen PM, Chiou TJ, Liu JH, Fan FS, Hsieh RK, Wei CH et al. Hepatitis C virus infection and chronic liver disease after bone marrow transplantation—the Taiwan experience. Transplant Proc 1993; 25 (4 Suppl 3): 65–66.

    PubMed  Google Scholar 

  20. Chen PM, Chiou TJ, Fan FS, Liu JM, Hsieh RK, Yen CC et al. Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation. Transplantation 1999; 67: 1425–1433.

    Article  CAS  Google Scholar 

  21. Hsiao LT, Chiou TJ, Liu JH, Chu CJ, Lin YC, Chao TC et al. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2006; 12: 84–94.

    Article  CAS  Google Scholar 

  22. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM . Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8: 417–420.

    CAS  PubMed  Google Scholar 

  23. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, Yang PC . Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1293–1297.

    Article  CAS  Google Scholar 

  24. Tzeng CH, Chen PM, Chiu CF, Chiou TJ, Hsien RK, Chuang MW et al. HLA-mismatched allogeneic bone marrow transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 1987; 39: 187–196.

    CAS  Google Scholar 

  25. Tzeng CH, Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh RK . CY/TBI-800 as a pre transplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Bone Marrow Transplant 1996; 18: 273–277.

    CAS  PubMed  Google Scholar 

  26. Chen PM, Chiou TJ, Hsieh RK, Tzeng CH, Wang WS, Yen CC et al. Bone marrow transplantation with HLA partially matched related donors. Zhonghua Yi Xue Za Zhi (Taipei) 1996; 58: 385–391.

    CAS  Google Scholar 

  27. Tzeng CH, Lin JS, Lee JC, Yung CH, Hu HY, Chen PM . Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor. Transfusion 1996; 36: 685–690.

    Article  CAS  Google Scholar 

  28. Lee MY, Chiou TJ, Yang MH, Bai LY, Hsiao LT, Chao TC et al. Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation. Eur J Haematol 2005; 74: 152–157.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Say-Bee Poh for the English editing of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T-J Chiou.

Additional information

Conflict of interest

None of the authors declared any financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, PM., Hsiao, LT., Chen, MH. et al. Current status of hematopoietic stem cell transplantation in Taiwan. Bone Marrow Transplant 42 (Suppl 1), S133–S136 (2008). https://doi.org/10.1038/bmt.2008.141

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.141

Keywords

This article is cited by

Search

Quick links